Li S F, Neethling F A, Taniguchi S, Yeh J C, Kobayashi T, Ye Y, Koren E, Cummings R D, Cooper D K
Oklahoma Transplantation Institute, Baptist Medical Center, Oklahoma City, USA.
Transplantation. 1996 Nov 15;62(9):1324-31. doi: 10.1097/00007890-199611150-00026.
The current shortage of donor organs has stimulated investigation of pig-to-human xenotransplantation as a practical alternative to allotransplantation. However, a major obstacle to this xenotransplantation is hyperacute rejection, which is believed to be initiated by the interaction of natural anti-alpha-galactosyl (alphaGal) antibodies with alphaGal epitopes on pig vascular endothelium. Previously, we reported that neutral oligosaccharides derived from porcine stomach mucin (PSM) are effective inhibitors of human anti-alphaGal IgG in vitro. We now report that O-glycans derived from PSM by beta-elimination (PSMO) reduce the cytotoxicity of both baboon and human sera to pig kidney (PK15) cells in vitro. Crude PSM had some inhibitory effect in vitro, but PSMO were more than 100 times more potent. Moreover, 1 microg/ml of beta-eliminated PSMO that bound to an immunoaffinity column of anti-alphaGal antibodies were four times more efficient than total PSMO in protecting PK15 cells from the cytotoxic effect of baboon or human sera. Blood recovered from baboons after intravenous infusion of PMSO also showed significant protection of PK15 cells. We conclude that PSMO eluted from an anti-alphaGal immunoaffinity column demonstrate potent inhibitory effects against baboon and human serum cytotoxicity to PK15 cells in vitro and when administered intravenously. PSM may provide a cheap and readily available source of glycans that will be of therapeutic value in the prevention of hyperacute rejection.
目前供体器官的短缺促使人们研究猪到人的异种移植,将其作为同种异体移植的一种切实可行的替代方案。然而,这种异种移植的一个主要障碍是超急性排斥反应,据信这是由天然抗α-半乳糖基(αGal)抗体与猪血管内皮细胞上的αGal表位相互作用引发的。此前,我们报道了从猪胃粘蛋白(PSM)衍生的中性寡糖在体外是人类抗αGal IgG的有效抑制剂。我们现在报告,通过β-消除法从PSM衍生的O-聚糖(PSMO)在体外可降低狒狒和人血清对猪肾(PK15)细胞的细胞毒性。粗制PSM在体外有一定的抑制作用,但PSMO的效力要高出100倍以上。此外,与抗αGal抗体免疫亲和柱结合的1微克/毫升β-消除PSMO在保护PK15细胞免受狒狒或人血清的细胞毒性作用方面比总PSMO有效四倍。静脉注射PSMO后从狒狒体内回收的血液也显示出对PK15细胞有显著的保护作用。我们得出结论,从抗αGal免疫亲和柱洗脱的PSMO在体外以及静脉给药时,对狒狒和人血清对PK15细胞的细胞毒性具有强大的抑制作用。PSM可能提供一种廉价且易于获得的聚糖来源,在预防超急性排斥反应方面具有治疗价值。